Pharmaceutical News

RSS

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

CV Therapeutics has announced that it has initiated an approval-enabling study of Ranexa, which, if successful, could support approval of Ranexa for the treatment of chronic angina in a restricted patient population.

3 Aug 2004

FDA approval for mint flavor nicotine gum

Watson Pharmaceuticals announced today that it has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for nicotine polacrilex gum, mint flavor, in the 2 and 4 mg strengths.

3 Aug 2004

Aventis ships its influenza vaccine, Fluzone

Aventis began to ship its influenza vaccine (Fluzone(R), Influenza Virus Vaccine) today, meeting the company's goal to provide Fluzone vaccine to customers to allow health-care providers to plan successful immunization programs for the upcoming influenza season.

3 Aug 2004

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).

3 Aug 2004

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Metabasis Therapeutics has announced the initiation of a multi-center, multi- national Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate in chronic hepatitis B (HBV) infected patients.

3 Aug 2004

New Drug Application with the U.S. Food and Drug Administration for Tarceva

OSI Pharmaceuticals and Genentech have announced that OSI completed the submission of a New Drug Application with the U.S. Food and Drug Administration for Tarceva (erlotinib HCl),

3 Aug 2004

FDA approves two fixed-dose combination treatments for HIV-1 infection

The Food and Drug Administration has announced approved Epzicom (abacavir/lamivudine) and Truvada (tenofovir disoproxil/emtricitabine), two fixed-dose combination treatments for HIV-1 infection.

2 Aug 2004

Schering-Ploug will return more than $9 million to the Texas Medicaid program for the company’s fraudulent reporting of prices for drug Claritin

Texas Attorney General Greg Abbott has announced a settlement among Texas and other states with pharmaceutical giant Schering-Plough Inc. that will return more than $9 million to the Texas Medicaid program for the company’s fraudulent reporting of prices for the antihistamine drug Claritin.

2 Aug 2004

European recommended approval of Remicade for treatment of psoriatic arthritis

Committee for Medicinal Products for Human Use of the European Agency for the Evaluation of Medicinal Products has issued a positive opinion recommending approval of expanded labeling for REMICADE(R) (infliximab), in combination with methotrexate, for treatment of active and progressive psoriatic arthritis (PsA) in patients who have responded inadequately to disease modifying anti- rheumatic drugs (DMARDs).

2 Aug 2004

Requip significantly reduces periodic leg movements in patients with restless legs syndrome

New data published in the August issue of SLEEP shows that patients with primary Restless Legs Syndrome (RLS) and with periodic leg movements during sleep (PLMS), have fewer awakenings resulting from involuntary kicks when treated with GlaxoSmithKline's Requip (ropinirole HCl).

2 Aug 2004

Schering Plough to reimburse Washington's Medicaid program $3.57 million in Claritin case

Pharmaceutical manufacturer Schering Plough will reimburse Washington's Medicaid program $3.57 million in a nationwide settlement of allegations the drug maker failed to offer state Medicaid programs its best price for the popular antihistamine drug Claritin.

31 Jul 2004

Warning for counterfeit drugs simvastatin and carisoprodol recently imported from Mexico

The U.S. Food and Drug Administration has issued a public warning regarding counterfeit versions of the drugs simvastatin and carisoprodol that have recently been imported from Mexico to the U.S.

31 Jul 2004

Tablets which help recovering alcoholics stay off the drink

The United States Food and Drug Administration has approved Campral (acamprosate calcium) tablets which help recovering alcoholics to stay of the drink. Campral is manufactured by Forest Laboratories and Merck of Darmstadt, Germany.

29 Jul 2004

Medicare prescription drug plan for seniors and the disabled is providing substantial discounts on drugs

A study by the Kaiser Family Foundation shows that the Medicare prescription drug plan for seniors and the disabled is providing substantial discounts on drugs. In its report, the organization finds that prices have not been fluctuating as much as had been feared.

29 Jul 2004

Philadelphia diet drug trial completed

Wyeth has announced that the jury in the case of Rhonda Istnick and Henry Clepper v. Wyeth, et al. rendered its decision, finding in favor of the Company in the case brought by Ms. Istnick, while awarding Mr. Clepper compensatory damages in the amount of $48,000.

29 Jul 2004

Drug to fight virus from the herpes family in transplant patients moves forward in trials

A drug once considered for cancer chemotherapy is advancing in clinical trials to test its effectiveness in fighting a virus from the herpes family that threatens transplant patients.

29 Jul 2004

Pharmacy Care Alliance provides $2.9 million in savings to Medicare beneficiaries

The Pharmacy Care Alliance has announced that for the first seven weeks of its discount card program, Medicare beneficiaries saved an average of 40 percent on generic drugs and 23 percent on brand drugs when compared to retail pharmacy cash prices. Medicare beneficiaries in all U.S. states have used the Pharmacy Care Alliance card since June 1.

29 Jul 2004

Research collaboration to discover novel oral drugs for the treatment of viral infections

Sunesis Pharmaceuticals, Inc. and Merck & Co., Inc. have announced that they have entered into a multi-year research collaboration to discover novel oral drugs for the treatment of viral infections.

29 Jul 2004

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Eli Lilly and Company have announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration positively endorsed Alimta® (pemetrexed), an antifolate, for accelerated approval in the second-line treatment of non-small cell lung cancer.

29 Jul 2004

BMA ready to support overworked doctors who decide to take legal action

With the deadline for legal limits on junior doctors' hours only three days away, the BMA warns that it is ready to support overworked doctors who decide to take legal action.

28 Jul 2004

Pharmaceutical News

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

FDA approval for mint flavor nicotine gum

Aventis ships its influenza vaccine, Fluzone

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

New Drug Application with the U.S. Food and Drug Administration for Tarceva

FDA approves two fixed-dose combination treatments for HIV-1 infection

Schering-Ploug will return more than $9 million to the Texas Medicaid program for the company’s fraudulent reporting of prices for drug Claritin

European recommended approval of Remicade for treatment of psoriatic arthritis

Requip significantly reduces periodic leg movements in patients with restless legs syndrome

Schering Plough to reimburse Washington's Medicaid program $3.57 million in Claritin case

Warning for counterfeit drugs simvastatin and carisoprodol recently imported from Mexico

Tablets which help recovering alcoholics stay off the drink

Medicare prescription drug plan for seniors and the disabled is providing substantial discounts on drugs

Philadelphia diet drug trial completed

Drug to fight virus from the herpes family in transplant patients moves forward in trials

Pharmacy Care Alliance provides $2.9 million in savings to Medicare beneficiaries

Research collaboration to discover novel oral drugs for the treatment of viral infections

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

BMA ready to support overworked doctors who decide to take legal action

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News